Open
NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
National Institutes of Health·Government
AI Summary
The National Institutes of Health is seeking small businesses to participate in the Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award. This award aims to support innovative research and development in various areas of health and medicine. The opportunity is open to small businesses that meet specific eligibility requirements.
Full Description
Title: NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Agency: National Institutes of Health
Agency Code: HHS-NIH11
Status: posted
Document Type: synopsis
Open Date: 05/28/2026
Close Date: 04/05/2029
CFDA Numbers: 93.853, 93.838, 93.839, 93.866, 93.307, 93.847, 93.394, 93.837, 93.855, 93.313, 93.393, 93.865, 93.350, 93.242, 93.867, 93.233, 93.351, 93.840, 93.859, 93.273, 93.395
Opportunity Number: PA-27-101
Opportunity ID: 359758